Fig. 2From: Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesionsClinical Events After EVT within 5 Years. a freedom from recurrent restenosis, b freedom from TLR, and c survival rate. CI indicates confidence intervals; HR, hazard ratio; ISR, in-stent restenosis; PCB, paclitaxel-coated balloon; TLR, target lesion revascularizationBack to article page